BOI:EPA
Boiron USA
19,20 €
arrow_upward
+0,79%(+0,15) 1D
13 նոյ, 17:35:27 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
19,25 €
High
19,25 €
Low
18,95 €
Mkt. cap
330,69 մլն
Avg. vol.
4,88 հզր
Volume
1,71 հզր
P/E ratio
12,73
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 մլն
No. of employees
3 հզր
Open
19,25 €
High
19,25 €
Low
18,95 €
Mkt. cap
330,69 մլն
Avg. vol.
4,88 հզր
Volume
1,71 հզր
P/E ratio
12,73
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
BigGo Finance
·
38 րոպե առաջ
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
TheStreet
·
1 ժամ առաջ
Goldman Sachs reset S&P 500 price target for 2027
TradingKey
·
11 ժամ առաջ
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
StoneX
·
2 օր առաջ
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron USA